Suppr超能文献

5,6-二氢-5-氮杂胞苷的细胞代谢及其掺入人淋巴细胞CEM/O和CEM/dCk(-)的DNA和RNA中。

Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-).

作者信息

Avramis V I, Powell W C, Mecum R A

机构信息

Department of Pediatrics, School of Medicine, University of Southern California, Los Angeles 90027.

出版信息

Cancer Chemother Pharmacol. 1989;24(3):155-60. doi: 10.1007/BF00300235.

Abstract

5,6-Dihydro-5-azacytidine (DHAC) is a hydrolytically stable analog of 5-azacytidine (5-aza-C) that has antileukemic activity against experimental leukemias and, like 5-aza-C, causes DNA hypomethylation. We report the cellular metabolism of DHAC and its incorporation into nucleic acids in the CCRF/CEM/O and deoxycytidine kinase mutant CCRF/CEM/dCk(-) human lymphoid cell lines. The cells were incubated with their respective IC50 concentrations for 24 h, then aliquot samples were removed at predetermined intervals and extracted for nucleotides. The acid-soluble extracts of the cells were assayed on HPLC for nucleotides of DHAC. The major anabolite of [3H]DHAC, [3H]DHACTP, peaked at 110.3 +/- 30.7 microM in CEM/O and at 96.3 +/- 41.9 microM in CEM/dCk(-) cells at 9 and 12 h, respectively. The intracellular concentrations of the deoxyribonucleoside triphosphate, [3H]DHAdCTP, peaked at 13.5 +/- 7.7 microM at 4 h in CEM/O and at 80.8 +/- 13.8 microM at 12 h, a 6-fold greater cellular concentration, in the dCk mutant cell line. The amount of DHAC anabolites incorporated into CEM/O nucleic acids reached a plateau in RNA at 552.6 +/- 7.8 pmol/10(7) cells and in DNA at 64.55 +/- 10.0 pmol/10(7) cells. In CEM/dCk(-) cells, DHAC anabolites reached a plateau in RNA and DNA at 4,256.3 +/- 631.0 and 395.5 +/- 145.4 pmol/10(7) cells, respectively. Thus, with equitoxic treatments of DHAC, the incorporation of its analog anabolites into RNA and DNA was 8- and 6-fold greater in CEM/dCk(-) cells. DNA methylation levels were depressed equally despite a 6-fold greater incorporation of the analog in DNA in the CEM/dCk(-) cells indicating that hypomethylation may be saturated after DHAC treatment. The DNA methylation levels reached a nadir of 0.19% and 0.20% methyl-C (percentage of methylation) in the two cell lines at 6 and 12 h after the beginning of drug treatment and remained relatively constant for the duration of the 24-h treatment. A curve-linear relationship was obtained between the DNA methylation levels in both cell lines and the amounts of DHAC anabolite incorporated into DNA.

摘要

5,6 - 二氢 - 5 - 氮杂胞苷(DHAC)是5 - 氮杂胞苷(5 - aza - C)的一种水解稳定类似物,对实验性白血病具有抗白血病活性,并且与5 - aza - C一样,会导致DNA低甲基化。我们报告了DHAC在CCRF/CEM/O和脱氧胞苷激酶突变体CCRF/CEM/dCk(-)人淋巴母细胞系中的细胞代谢及其掺入核酸的情况。将细胞用各自的IC50浓度孵育24小时,然后在预定时间间隔取出等分试样并提取核苷酸。细胞的酸溶性提取物通过HPLC测定DHAC的核苷酸。[3H]DHAC的主要合成代谢产物[3H]DHACTP在CEM/O细胞中于9小时达到峰值,为110.3±30.7 microM,在CEM/dCk(-)细胞中于12小时达到峰值,为96.3±41.9 microM。脱氧核糖核苷三磷酸[3H]DHAdCTP的细胞内浓度在CEM/O细胞中于4小时达到峰值,为13.5±7.7 microM,而在dCk突变细胞系中于12小时达到峰值,为80.8±13.8 microM,细胞内浓度高6倍。掺入CEM/O核酸中的DHAC合成代谢产物的量在RNA中达到稳定水平,为552.6±7.8 pmol/10(7)细胞,在DNA中为64.55±10.0 pmol/10(7)细胞。在CEM/dCk(-)细胞中,DHAC合成代谢产物在RNA和DNA中分别于4256.3±631.0和395.5±145.4 pmol/10(7)细胞时达到稳定水平。因此,用等毒性的DHAC处理时,其类似物合成代谢产物在CEM/dCk(-)细胞中掺入RNA和DNA的量分别高8倍和6倍。尽管在CEM/dCk(-)细胞中类似物掺入DNA的量高6倍,但DNA甲基化水平同样降低,这表明DHAC处理后低甲基化可能已饱和。在药物处理开始后6小时和12小时,两种细胞系中的DNA甲基化水平分别降至最低点,甲基 - C为0.19%和0.20%(甲基化百分比),并且在24小时处理期间保持相对稳定。在两种细胞系中,DNA甲基化水平与掺入DNA的DHAC合成代谢产物的量之间获得了曲线 - 线性关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验